The COLchicine and Atrial FIBrillation Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT05928728

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05928728
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05928728. Randomized; quadruple masking; primary purpose treatment. Start 2023-07-03 (actual); primary completion 2026-06-14 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The COLchicine and Atrial FIBrillation Trial
Acronym
COLFIB
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Herlev and Gentofte Hospital (class: other)

Record details

Record id
cardio:ct-nct05928728
Content hash
c247e018e18af78e6c3f5463b197c589ea02da92d8d5ffd24eb0b2735f13035c